• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CYP21基因中的一个突变(第30位脯氨酸突变为亮氨酸)代表一种潜在的非经典型类固醇21-羟化酶缺乏等位基因。

A mutation (Pro-30 to Leu) in CYP21 represents a potential nonclassic steroid 21-hydroxylase deficiency allele.

作者信息

Tusie-Luna M T, Speiser P W, Dumic M, New M I, White P C

机构信息

Division of Pediatric Endocrinology, Cornell University Medical College, New York 10021.

出版信息

Mol Endocrinol. 1991 May;5(5):685-92. doi: 10.1210/mend-5-5-685.

DOI:10.1210/mend-5-5-685
PMID:2072928
Abstract

The mild nonclassic form of steroid 21-hydroxylase deficiency is one of the most common autosomal recessive disorders in humans, occurring in almost 1% of caucasians and about 3% of Ashkenazi Jews. Many patients with this disorder carry a Val-281----Leu missense mutation in the CYP21 gene. This and most other mutations causing 21-hydroxylase deficiency are normally present in the CYP21P pseudogene and have presumably been transferred to CYP21 by gene conversion. To identify other potential nonclassic alleles, we used recombinant vaccinia virus to express two mutant enzymes carrying the mutations Pro-30----Leu (normally present in CYP21P) and Ser-268----Thr (considered a normal polymorphism of CYP21). Whereas the activity of the protein carrying the Ser----Thr mutation was indeed indistinguishable from the wild type, the enzyme with the Pro----Leu substitution had 60% of wild-type activity for 17-hydroxyprogesterone and about 30% of normal activity for progesterone when assayed in intact cells. When kinetic analysis of the latter mutant enzyme was performed in cellular lysates, the first order rate constants (maximum velocity/dissociation constant) for both substrates were reduced 10- to 20-fold compared with those for the wild-type enzyme. Pro-30 is conserved in many microsomal P450 enzymes and may be important for proper orientation of the enzyme with respect to the aminoterminal transmembrane segment. The Pro----Leu mutation was present in 5 of 18 patients with nonclassic 21-hydroxylase deficiency, suggesting that this mutation indeed acts as a nonclassic deficiency allele.

摘要

类固醇21-羟化酶缺乏症的轻度非经典形式是人类最常见的常染色体隐性疾病之一,在近1%的白种人和约3%的德系犹太人中出现。许多患有这种疾病的患者在CYP21基因中携带Val-281----Leu错义突变。导致21-羟化酶缺乏的这种突变和大多数其他突变通常存在于CYP21P假基因中,并且据推测已通过基因转换转移到CYP21。为了鉴定其他潜在的非经典等位基因,我们使用重组痘苗病毒来表达两种携带突变Pro-30----Leu(通常存在于CYP21P中)和Ser-268----Thr(被认为是CYP21的正常多态性)的突变酶。携带Ser----Thr突变的蛋白质的活性确实与野生型无法区分,而在完整细胞中进行检测时,具有Pro----Leu替代的酶对17-羟孕酮的活性为野生型活性的60%,对孕酮的活性约为正常活性的30%。当在细胞裂解物中对后一种突变酶进行动力学分析时,与野生型酶相比,两种底物的一级速率常数(最大速度/解离常数)降低了10至20倍。Pro-30在许多微粒体P450酶中是保守的,并且可能对于酶相对于氨基末端跨膜区段的正确取向很重要。Pro----Leu突变存在于18例非经典21-羟化酶缺乏症患者中的5例中,表明该突变确实作为一种非经典缺乏等位基因起作用。

相似文献

1
A mutation (Pro-30 to Leu) in CYP21 represents a potential nonclassic steroid 21-hydroxylase deficiency allele.CYP21基因中的一个突变(第30位脯氨酸突变为亮氨酸)代表一种潜在的非经典型类固醇21-羟化酶缺乏等位基因。
Mol Endocrinol. 1991 May;5(5):685-92. doi: 10.1210/mend-5-5-685.
2
R339H and P453S: CYP21 mutations associated with nonclassic steroid 21-hydroxylase deficiency that are not apparent gene conversions.
Mol Endocrinol. 1992 Aug;6(8):1318-22. doi: 10.1210/mend.6.8.1406709.
3
Pro-453 to Ser mutation in CYP21 is associated with nonclassic steroid 21-hydroxylase deficiency.细胞色素P450 21(CYP21)基因中脯氨酸453突变为丝氨酸与非经典型类固醇21-羟化酶缺乏症相关。
Mol Endocrinol. 1992 Aug;6(8):1211-5. doi: 10.1210/mend.6.8.1406699.
4
How a patient homozygous for a 30-kb deletion of the C4-CYP 21 genomic region can have a nonclassic form of 21-hydroxylase deficiency.一名C4-CYP 21基因组区域存在30千碱基缺失的纯合子患者如何会患有非典型形式的21-羟化酶缺乏症。
J Clin Endocrinol Metab. 2000 Dec;85(12):4562-7. doi: 10.1210/jcem.85.12.7018.
5
CYP21 gene mutation analysis in 198 patients with 21-hydroxylase deficiency in The Netherlands: six novel mutations and a specific cluster of four mutations.荷兰198例21-羟化酶缺乏症患者的CYP21基因突变分析:六个新突变及一个四个突变的特定簇。
J Clin Endocrinol Metab. 2003 Aug;88(8):3852-9. doi: 10.1210/jc.2002-021681.
6
Mutations in steroid 21-hydroxylase (CYP21).类固醇21-羟化酶(CYP21)突变。
Hum Mutat. 1994;3(4):373-8. doi: 10.1002/humu.1380030408.
7
Screening of CYP21 gene mutations in 129 French patients affected by steroid 21-hydroxylase deficiency.对129名患有类固醇21-羟化酶缺乏症的法国患者进行CYP21基因突变筛查。
Hum Mutat. 1995;5(2):126-30. doi: 10.1002/humu.1380050205.
8
Nonisotopic identification of two point mutations in the CYP21 gene responsible for nonclassic 21-hydroxylase deficiency.CYP21基因中导致非典型21-羟化酶缺乏的两个点突变的非同位素鉴定。
Biochem Med Metab Biol. 1994 Aug;52(2):85-8. doi: 10.1006/bmmb.1994.1037.
9
Functional characterization of two novel point mutations in the CYP21 gene causing simple virilizing forms of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.CYP21基因中两个导致21-羟化酶缺乏引起单纯男性化型先天性肾上腺皮质增生的新型点突变的功能特征
J Clin Endocrinol Metab. 2005 Jan;90(1):445-54. doi: 10.1210/jc.2004-0813. Epub 2004 Oct 13.
10
Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.21-羟化酶缺乏所致先天性肾上腺皮质增生症的疾病表现及分子基因型
J Clin Invest. 1992 Aug;90(2):584-95. doi: 10.1172/JCI115897.

引用本文的文献

1
Genetics and Pathophysiology of Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency.21-羟化酶缺乏所致经典型先天性肾上腺皮质增生症的遗传学与病理生理学
J Clin Endocrinol Metab. 2025 Jan 21;110(Supplement_1):S1-S12. doi: 10.1210/clinem/dgae535.
2
Comparison of long-read sequencing and MLPA combined with long-PCR sequencing of mutations in patients with 21-OHD.21-羟化酶缺乏症患者突变的长读长测序与MLPA联合长PCR测序的比较
Front Genet. 2024 Nov 1;15:1472516. doi: 10.3389/fgene.2024.1472516. eCollection 2024.
3
Approaching fertility in congenital adrenal hyperplasia: exploring P30L mutation-induced 21-hydroxylase deficiency with a presentation between non-classical and simple virilizing phenotypes. A case report.
先天性肾上腺皮质增生症的生育问题探讨:研究P30L突变导致的21-羟化酶缺乏症,其表现介于非经典型和单纯男性化型之间。病例报告
Med Pharm Rep. 2024 Apr;97(2):234-238. doi: 10.15386/mpr-2580. Epub 2024 Apr 25.
4
The underlying cause of the simple virilizing phenotype in patients with 21-hydroxylase deficiency harboring P31L variant.21-羟化酶缺陷症患者中携带 P31L 变异体的单纯男性化表型的潜在病因。
Front Endocrinol (Lausanne). 2023 Feb 14;13:1015773. doi: 10.3389/fendo.2022.1015773. eCollection 2022.
5
Therapeutic needs from early childhood in four patients with 21-hydroxylase deficiency harboring the P30L mutation on one allele.4例单等位基因携带P30L突变的21-羟化酶缺乏症患儿的治疗需求。
Clin Pediatr Endocrinol. 2021;30(4):187-193. doi: 10.1297/cpe.30.187. Epub 2021 Oct 1.
6
Genotypic spectrum of 21-hydroxylase deficiency in an endogamous population.21-羟化酶缺陷症在一个近亲通婚人群中的基因谱。
J Endocrinol Invest. 2022 Feb;45(2):347-359. doi: 10.1007/s40618-021-01648-8. Epub 2021 Aug 2.
7
Congenital Adrenal Hyperplasia-Current Insights in Pathophysiology, Diagnostics, and Management.先天性肾上腺皮质增生症-病理生理学、诊断和治疗的最新见解。
Endocr Rev. 2022 Jan 12;43(1):91-159. doi: 10.1210/endrev/bnab016.
8
Clinical outcomes and characteristics of P30L mutations in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.21-羟化酶缺陷导致先天性肾上腺皮质增生中 P30L 突变的临床结局和特征。
Endocrine. 2020 Aug;69(2):262-277. doi: 10.1007/s12020-020-02323-3. Epub 2020 May 5.
9
The Complexities in Genotyping of Congenital Adrenal Hyperplasia: 21-Hydroxylase Deficiency.先天性肾上腺皮质增生症基因分型的复杂性:21-羟化酶缺乏症
Front Endocrinol (Lausanne). 2019 Jul 4;10:432. doi: 10.3389/fendo.2019.00432. eCollection 2019.
10
The impact of CYP21A2 (P30L/I172N) genotype on female fertility in one family.CYP21A2(P30L/I172N)基因型对一个家系中女性生育力的影响。
Eur J Med Res. 2019 Jun 19;24(1):21. doi: 10.1186/s40001-019-0379-4.